Literature DB >> 30889378

Integrin Signaling in Cancer: Mechanotransduction, Stemness, Epithelial Plasticity, and Therapeutic Resistance.

Jonathan Cooper1, Filippo G Giancotti2.   

Abstract

Integrins mediate cell adhesion and transmit mechanical and chemical signals to the cell interior. Various mechanisms deregulate integrin signaling in cancer, empowering tumor cells with the ability to proliferate without restraint, to invade through tissue boundaries, and to survive in foreign microenvironments. Recent studies have revealed that integrin signaling drives multiple stem cell functions, including tumor initiation, epithelial plasticity, metastatic reactivation, and resistance to oncogene- and immune-targeted therapies. Here, we discuss the mechanisms leading to the deregulation of integrin signaling in cancer and its various consequences. We place emphasis on novel functions, determinants of context dependency, and mechanism-based therapeutic opportunities.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  FAK signaling; cancer stem cell; extracellular niche; integrins; mechanotransduction; metastasis and invasion; receptor tyrosine kinase; therapeutic resistance; therapeutic targeting of integrins; tumor microenvironment

Mesh:

Substances:

Year:  2019        PMID: 30889378      PMCID: PMC6684107          DOI: 10.1016/j.ccell.2019.01.007

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  231 in total

1.  Distinct selectin ligands on colon carcinoma mucins can mediate pathological interactions among platelets, leukocytes, and endothelium.

Authors:  Y J Kim; L Borsig; H L Han; N M Varki; A Varki
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

Review 2.  Mechanisms governing metastatic dormancy and reactivation.

Authors:  Filippo G Giancotti
Journal:  Cell       Date:  2013-11-07       Impact factor: 41.582

3.  A vascular niche and a VEGF-Nrp1 loop regulate the initiation and stemness of skin tumours.

Authors:  Benjamin Beck; Gregory Driessens; Steven Goossens; Khalil Kass Youssef; Anna Kuchnio; Amélie Caauwe; Panagiota A Sotiropoulou; Sonja Loges; Gaelle Lapouge; Aurélie Candi; Guilhem Mascre; Benjamin Drogat; Sophie Dekoninck; Jody J Haigh; Peter Carmeliet; Cédric Blanpain
Journal:  Nature       Date:  2011-10-19       Impact factor: 49.962

4.  Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma.

Authors:  Miriam Benezra; Oula Penate-Medina; Pat B Zanzonico; David Schaer; Hooisweng Ow; Andrew Burns; Elisa DeStanchina; Valerie Longo; Erik Herz; Srikant Iyer; Jedd Wolchok; Steven M Larson; Ulrich Wiesner; Michelle S Bradbury
Journal:  J Clin Invest       Date:  2011-06-13       Impact factor: 14.808

5.  Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice.

Authors:  Jean Albrengues; Mario A Shields; David Ng; Chun Gwon Park; Alexandra Ambrico; Morgan E Poindexter; Priya Upadhyay; Dale L Uyeminami; Arnaud Pommier; Victoria Küttner; Emilis Bružas; Laura Maiorino; Carmelita Bautista; Ellese M Carmona; Phyllis A Gimotty; Douglas T Fearon; Kenneth Chang; Scott K Lyons; Kent E Pinkerton; Lloyd C Trotman; Michael S Goldberg; Johannes T-H Yeh; Mikala Egeblad
Journal:  Science       Date:  2018-09-28       Impact factor: 47.728

6.  Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction.

Authors:  Donald E White; Natasza A Kurpios; Dongmei Zuo; John A Hassell; Sandra Blaess; Ulrich Mueller; William J Muller
Journal:  Cancer Cell       Date:  2004-08       Impact factor: 31.743

7.  Matrix crosslinking forces tumor progression by enhancing integrin signaling.

Authors:  Kandice R Levental; Hongmei Yu; Laura Kass; Johnathon N Lakins; Mikala Egeblad; Janine T Erler; Sheri F T Fong; Katalin Csiszar; Amato Giaccia; Wolfgang Weninger; Mitsuo Yamauchi; David L Gasser; Valerie M Weaver
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

Review 8.  Contextual determinants of TGFβ action in development, immunity and cancer.

Authors:  Charles J David; Joan Massagué
Journal:  Nat Rev Mol Cell Biol       Date:  2018-07       Impact factor: 94.444

9.  CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin-TGFβ signaling.

Authors:  P-K Lo; D Kanojia; X Liu; U P Singh; F G Berger; Q Wang; H Chen
Journal:  Oncogene       Date:  2011-09-26       Impact factor: 9.867

10.  Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis.

Authors:  Nicola Aceto; Aditya Bardia; David T Miyamoto; Maria C Donaldson; Ben S Wittner; Joel A Spencer; Min Yu; Adam Pely; Amanda Engstrom; Huili Zhu; Brian W Brannigan; Ravi Kapur; Shannon L Stott; Toshi Shioda; Sridhar Ramaswamy; David T Ting; Charles P Lin; Mehmet Toner; Daniel A Haber; Shyamala Maheswaran
Journal:  Cell       Date:  2014-08-28       Impact factor: 41.582

View more
  167 in total

1.  Upregulation of CPNE3 suppresses invasion, migration and proliferation of glioblastoma cells through FAK pathway inactivation.

Authors:  Dijian Shi; Bo Lin; Jun Lai; Kaipeng Li; Yimo Feng
Journal:  J Mol Histol       Date:  2021-03-16       Impact factor: 2.611

2.  Activated nanoscale actin-binding domain motion in the catenin-cadherin complex revealed by neutron spin echo spectroscopy.

Authors:  Bela Farago; Iain D Nicholl; Shen Wang; Xiaolin Cheng; David J E Callaway; Zimei Bu
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-30       Impact factor: 11.205

3.  Senescent Stromal Cells Promote Cancer Resistance through SIRT1 Loss-Potentiated Overproduction of Small Extracellular Vesicles.

Authors:  Liu Han; Qilai Long; Shenjun Li; Qixia Xu; Boyi Zhang; Xuefeng Dou; Min Qian; Yannasittha Jiramongkol; Jianming Guo; Liu Cao; Y Eugene Chin; Eric W-F Lam; Jing Jiang; Yu Sun
Journal:  Cancer Res       Date:  2020-05-04       Impact factor: 12.701

Review 4.  Cryptic collagen elements as signaling hubs in the regulation of tumor growth and metastasis.

Authors:  XiangHua Han; Jennifer M Caron; Peter C Brooks
Journal:  J Cell Physiol       Date:  2020-05-12       Impact factor: 6.384

Review 5.  Cell adhesion in cancer: Beyond the migration of single cells.

Authors:  Michalina Janiszewska; Marina Candido Primi; Tina Izard
Journal:  J Biol Chem       Date:  2020-01-14       Impact factor: 5.157

Review 6.  Understanding the role of integrins in breast cancer invasion, metastasis, angiogenesis, and drug resistance.

Authors:  Hassan Yousefi; Mousa Vatanmakanian; Mojdeh Mahdiannasser; Ladan Mashouri; Nikhilesh V Alahari; Mohammad Rafiee Monjezi; Shahrzad Ilbeigi; Suresh K Alahari
Journal:  Oncogene       Date:  2021-01-08       Impact factor: 9.867

7.  Arming Tumor-Associated Macrophages to Reverse Epithelial Cancer Progression.

Authors:  Hiromi I Wettersten; Sara M Weis; Paulina Pathria; Tami Von Schalscha; Toshiyuki Minami; Judith A Varner; David A Cheresh
Journal:  Cancer Res       Date:  2019-08-15       Impact factor: 12.701

8.  Retinoic acid inducible gene-I slows down cellular senescence through negatively regulating the integrin β3/p38 MAPK pathway.

Authors:  Junmei Zhao; Xinyi Jiang; Li Yan; Jian Lin; Hezhou Guo; Shanhe Yu; Baixin Ye; Jiang Zhu; Wu Zhang
Journal:  Cell Cycle       Date:  2019-10-09       Impact factor: 4.534

Review 9.  Molecular Chaperones in Cancer Stem Cells: Determinants of Stemness and Potential Targets for Antitumor Therapy.

Authors:  Alexander Kabakov; Anna Yakimova; Olga Matchuk
Journal:  Cells       Date:  2020-04-06       Impact factor: 6.600

10.  ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin α3β1 Signaling and Inhibit Expression of the Gemcitabine Transporter ENT1 in Pancreatic Cancer Cells.

Authors:  Mingyang Liu; Yuqing Zhang; Jingxuan Yang; Xiaobo Cui; Zhijun Zhou; Hanxiang Zhan; Kai Ding; Xiang Tian; Zhibo Yang; Kar-Ming A Fung; Barish H Edil; Russell G Postier; Michael S Bronze; Martin E Fernandez-Zapico; Marc P Stemmler; Thomas Brabletz; Yi-Ping Li; Courtney W Houchen; Min Li
Journal:  Gastroenterology       Date:  2019-11-09       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.